Publications

Filters: Author is Helfand, S C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, Auerbach R, Helfand SC.  2004.  Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.. Neoplasia (New York, N.Y.). 6(2):106-16. Abstract
B
Bianco SR, Sun J, Fosmire SP, Hance K, Padilla ML, Ritt MG, Getzy DM, Duke RC, Withrow SJ, Lana S et al..  2003.  Enhancing antimelanoma immune responses through apoptosis.. Cancer gene therapy. 10(9):726-36. Abstract
D
Dickerson EB, Akhtar N, Steinberg H, Wang Z-Y, Lindstrom MJ, Padilla ML, Auerbach R, Helfand SC.  2004.  Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin.. Molecular cancer research : MCR. 2(12):663-73. Abstract
Dickerson EB, Fosmire S, Padilla ML, Modiano JF, Helfand SC.  2002.  Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer.. Journal of immunotherapy (Hagerstown, Md. : 1997). 25(1):36-45. Abstract
Dickerson EB, Thomas R, Fosmire SP, Lamerato-Kozicki AR, Bianco SR, Wojcieszyn JW, Breen M, Helfand SC, Modiano JF.  2005.  Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.. Veterinary pathology. 42(5):618-32. Abstract
F
Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VEO, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS et al..  2007.  Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.. Veterinary pathology. 44(4):467-78. Abstract
Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM et al..  2004.  Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium.. Laboratory investigation; a journal of technical methods and pathology. 84(5):562-72. Abstract
Fox LE, Rosenthal RC, King RR, Levine PB, Vail DM, Helfand SC, MacEwen EG, Perez-Soler R, Calderwood-Mays M, Kurzman ID.  2000.  Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.. American journal of veterinary research. 61(7):791-5. Abstract
Fox LE, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Vail DM, Kisseberth W, London C, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.. Cancer biotherapy. 10(2):125-30. Abstract
H
Helfand SC, Soergel SA, Modiano JF, Hank JA, Sondel PM.  1994.  Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro.. Cancer biotherapy. 9(3):237-44. Abstract